BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $1.279B (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 52.0%

Value $665M Shares 10,799,410 Est. Cost $8.21 Unrealized +397.5%

MNST MONSTER BEVERAGE CORP NEW 25.2%

Value $323M Shares 4,656,488 Est. Cost $22.71 Unrealized +43.8%

IWM ISHARES TR 12.3%

Value $157M Shares 1,095,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 5.8%

Value $74.58M Shares 760,062 Est. Cost $27.50 Unrealized +194.1%

LCTX LINEAGE CELL THERAPEUTICS IN 2.3%

Value $29.59M Shares 34,005,379 Est. Cost $1.03 Unrealized -14.6%

— ONCOCYTE CORP 2.2%

Value $28.11M Shares 14,716,204 Est. Cost $3.13 Unrealized —

— AGEX THERAPEUTICS INC 0.2%

Value $2.837M Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,799,410	$665M	52.0%	$8.21	+397.5%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$323M	25.2%	$22.71	+43.8%	COM	61174X109
IWM	ISHARES TR	1,095,000	$157M	12.3%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$74.58M	5.8%	$27.50	+194.1%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$29.59M	2.3%	$1.03	-14.6%	COM	53566P109
—	ONCOCYTE CORP	14,716,204	$28.11M	2.2%	$3.13	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$2.837M	0.2%	$2.99	—	COM	00848H108